- Colombian cannabis cultivator and international wellness product builder Flora Growth Corp. is building a global pipeline for its wide array of branded CBD and medicinal cannabis products
- The company recently announced that it has begun fulfilling the first orders for its Mind Naturals and Awe CBD skincare brands with exports to Spain and Mexico outlets this month
- Flora Growth cultivates cannabis at its 100-hectare (247-acre) property in central Colombia
- Flora also has a GMP certified 16,000-square-foot manufacturing facility in Bogota that produces nearly 200 products for the CBD derivatives and medical cannabis markets
Cannabis cultivator and worldwide cannabidiol (“CBD”) brand builder Flora Growth (NASDAQ: FLGC) continues to expand its consumer product goods and wellness lifestyle technology internationally, recently receiving its first orders for its Mind Naturals and Awe CBD skincare brands from outlets in Spain and Mexico.
The company’s e-commerce agreements with SHOWFIELDS and GlossWire’s digital beauty marketplace in October paved the way for the two skincare brands to roll out in international markets. Fulfillment of these initial purchase orders from Amma Spain and Mexico’s Evergreen CBD is anticipated as the company’s product is exported this month. Mind Naturals markets to young, incoming consumers while Awe provides a customizable experience to the prestige market.
“After months of preparation, our products meet all the needs of today’s consumers and we are ready for new international markets,” Flora Beauty General Manager Andrew Restrepo stated in announcing the product orders (https://cnw.fm/0sqH1). “Incorporating cutting edge formulations, rigorous safety standards and sustainable packaging, we are confident that our products are positioned to be among the best in the beauty industry and pleased that recent industry recognition supports this.”
The announcement states Mind Naturals has garnered praise from industry marketing firms and that Spain is gaining a CBD hub reputation as a country poised to serve as the exporter for the industry’s products to surrounding countries.
Flora Growth’s Flora Lab division serves as the company’s base for research, development and manufacturing of pharmaceuticals, cosmetics and nutraceuticals with 3 GMP certifications.
Earlier this year, a major positive development in Colombia’s legal outlook on exporting dried cannabis flower and producing cannabis food and beverage products has made Flora Growths’ operational buildup pay off. Flora has now developed an international distribution pipeline for its GACP-certified flower produced at its Colombian facilities – where GACP is the precursor certification for the flower to be used to produce EU-GMP certified derivatives – that can be marketed to end users around the world.
Flora also completed an investment program in European Union GMP partner Hoshi International Inc. in August that is expected to create a pathway for European distribution of Flora’s medical cannabis products (https://cnw.fm/rqK2L).
Flora Growth President and CEO Luis Merchan will provide an update in a Dec. 14 webinar on the company’s performance for 2021 and comment on the company’s financial guidance for 2022 (https://cnw.fm/vBuXS).
For more information, visit the company’s website at www.FloraGrowth.ca.
NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Do you have questions or are you interested in working with CNW? Ask Our Editor
CBDWire is part of the InvestorBrandNetwork.